India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
Approval based on DUO-E trial results, which showed Imfinzi reduced the risk of disease progression or death by 58% vs. chemotherapy
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
New software solution helps manufacturers digitalize and gain insights from data to increase efficiency
Nadda also interacted with senior officials of the Union Health Ministry after taking charge where he was briefed about the ongoing projects
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
The special Tele MANAS cell to serve as a dedicated mental health assistance helpline for all Armed Forces beneficiaries across country
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Subscribe To Our Newsletter & Stay Updated
